Establishment and characterization of a murine model for allergic asthma using allergen-specific IgE monoclonal antibody to study pathological roles of IgE

Immunology Letters

Volumn 141, Issue 2, 2012, Pages 235-245

  Mizutani, Nobuaki ^a   Goshima, Hirofumi ^a   Nabe, Takeshi ^b   Yoshino, Shin ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Airway hyperresponsiveness; Airway remodeling; Early asthmatic response; IgE; Late asthmatic response; Monoclonal antibody

Indexed keywords

COMPLEMENT COMPONENT C3A; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN E MONOCLONAL ANTIBODY; IMMUNOGLOBULIN G1; OVALBUMIN; UNCLASSIFIED DRUG;

AIRWAY OBSTRUCTION; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; CELL HYPERPLASIA; CONTROLLED STUDY; DRUG RECHALLENGE; GOBLET CELL; IMMUNE RESPONSE; LUNG; LYMPHOCYTE COUNT; MACROPHAGE; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; NONHUMAN; PASSIVE ANAPHYLAXIS; PRIORITY JOURNAL; SCID MOUSE; SENSITIZATION;

ALLERGENS; ANIMALS; ANTIGEN-ANTIBODY COMPLEX; ARGININE; ASTHMA; BENZHYDRYL COMPOUNDS; BRONCHIAL HYPERREACTIVITY; CELL MOVEMENT; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; GOBLET CELLS; HUMANS; HYPERPLASIA; IMMUNIZATION; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; NEUTROPHILS; OVALBUMIN; RECEPTORS, COMPLEMENT;

EID: 84855933204     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2011.10.010     Document Type: Article

References (51)

1. Cohn L., Elias J.A., Chupp G.L. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 2004, 22:789-815.
2. Robinson D.S., Hamid Q., Ying S., Tsicopoulos A., Barkans J., Bentley A.M., et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992, 326:298-304.
3. Herxheimer H. The late bronchial reaction in induced asthma. Int Arch Allergy Appl Immunol 1952, 3:323-328.
4. Cockcroft D.W., Ruffin R.E., Dolovich J., Hargreave F.E. Allergen-induced increase in nonallergic bronchial reactivity. Clin Allergy 1977, 7:503-513.
5. Durham S.R. The significance of late responses in asthma. Clin Exp Allergy 1991, 21:3-7.
6. Galli S.J. Mast cell and basophils. Curr Opin Hematol 2000, 7:32-39.
7. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M., Tsai M. Mast cells as " tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005, 23:749-786.
8. Kawakami T., Galli S.J. Regulation of mast cell and basophil function and survival by IgE. Nat Rev Immunol 2002, 2:773-786.
9. Pauwels R. The relationship between airway inflammation and bronchial hyperresponsiveness. Clin Exp Allergy 1989, 19:395-398.
10. Bousquet J., Chanez P., Lacoste J.Y., Barneon G., Ghavanian N., Enander I., et al. Eosinophilic inflammation in asthma. N Engl J Med 1990, 323:1033-1039.
11. De Monchy J.G., Kauffman H.F., Venge P., Koeter G.H., Jansen H.M., Sluiter H.J., et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985, 131:373-376.
12. Aikawa T., Shimura S., Sasaki H., Ebina M., Takishima T. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest 1992, 101:916-921.
13. Ebina M., Takahashi T., Chiba T., Motomiya M. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am Rev Respir Dis 1993, 148:720-726.
14. Hossain S., Heard B.E. Hyperplasia of bronchial muscle in chronic bronchitis. J Pathol 1970, 101:171-184.
15. Jeffery P.K., Godfrey R.W., Adelroth E., Nelson F., Rogers A., Johansson S.A. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. Am Rev Respir Dis 1992, 145:890-899.
16. Roche W.R., Beasley R., Williams J.H., Holgate S.T. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989, 1:520-524.
17. Zweiman B. The late-phase reaction: role of IgE, its receptor and cytokines. Curr Opin Immunol 1993, 5:950-955.
18. Oshiba A., Hamelmann E., Takeda K., Bradley K.L., Loader J.E., Larsen G.L., et al. Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice. J Clin Invest 1996, 97:1398-1408.
19. Nabe T., Zindl C.L., Jung Y.W., Stephens R., Sakamoto A., Kohno S., et al. Induction of a late asthmatic response associated with airway inflammation in mice. Eur J Pharmacol 2005, 521:144-155.
20. Mizutani N., Nabe T., Yoshino S. Complement C3a regulates late asthmatic response and airway hyperresponsiveness in mice. J Immunol 2009, 183:4039-4046.
21. Yamaki K., Yoshino S. Comparison of inhibitory activities of zinc oxide ultrafine and fine particulates on IgE-induced mast cell activation. Biometals 2009, 22:1031-1040.
22. Pennock B.E., Cox C.P., Rogers R.M., Cain W.A., Wells J.H. A noninvasive technique for measurement of changes in specific airway resistance. J Appl Physiol 1979, 46:399-406.
23. Yamaki K., Uchida H., Harada Y., Yanagisawa R., Takano H., Hayashi H., et al. Effect of the nonsteroidal anti-inflammatory drug indomethacin on Th1 and Th2 immune responses in mice. J Pharm Sci 2003, 92:1723-1729.
24. Matsumura M., Nagata M., Nakamura K., Kawai M., Baba T., Yamaki K., et al. Adjuvant effect of zinc oxide on Th2 but not Th1 immune responses in mice. Immunopharmacol Immunotoxicol 2010, 32:56-62.
25. Banda N.K., Takahashi K., Wood A.K., Holers V.M., Arend W.P. Pathogenic complement activation in collagen antibody-induced arthritis in mice requires amplification by the alternative pathway. J Immunol 2007, 179:4101-4109.
26. Hutamekalin P., Takeda K., Tani M., Tsuga Y., Ogawa N., Mizutani N., et al. Effect of the C3a-receptor antagonist SB290157 on anti-OVA polyclonal antibody-induced arthritis. J Pharmacol Sci 2010, 112:56-63.
27. Fujiwara H., Kikutani H., Suematsu S., Naka T., Yoshida K., Yoshida K., et al. The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice. Proc Natl Acad Sci USA 1994, 91:6835-6839.
28. + B cells. J Immunol 2005, 175:1473-1482.
29. Gustavsson S., Hjulstrom S., Liu T., Heyman B. CD23/IgE-mediated regulation of the specific antibody response in vivo. J Immunol 1994, 152:4793-4800.
30. + spleen or bone marrow cells. J Immunol 2000, 164:3990-3995.
31. Heyman B., Tianmin L., Gustavsson S. In vivo enhancement of the specific antibody response via the low-affinity receptor for IgE. Eur J Immunol 1993, 23:1739-1742.
32. Kehry M.R., Yamashita L.C. Low-affinity IgE receptor (CD23) function on mouse B cells: role in IgE-dependent antigen focusing. Proc Natl Acad Sci USA 1989, 86:7556-7560.
33. Pirron U., Schlunck T., Prinz J.C., Rieber E.P. IgE-dependent antigen focusing by human B lymphocytes is mediated by the low-affinity receptor for IgE. Eur J Immunol 1990, 20:1547-1551.
34. Yoshimoto T., Yasuda K., Tanaka H., Nakahira M., Imai Y., Fujimori Y., et al. Basophils contribute to T(H)2-IgE responses in vivo via IL-4 production and presentation of peptide-MHC class II complexes to CD4+ T cells. Nat Immunol 2009, 10:706-712.
35. Drouin S.M., Kildsgaard J., Haviland J., Zabner J., Jia H.P., McCray P.B., et al. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. J Immunol 2001, 166:2025-2032.
36. Martin U., Bock D., Arseniev L., Tornetta M.A., Ames R.S., Bautsch W., et al. The human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytes. J Exp Med 1997, 186:199-207.
37. Werfel T., Kirchhoff K., Wittmann M., Begemann G., Kapp A., Heidenreich F., et al. Activated human T lymphocytes express a functional C3a receptor. J Immunol 2000, 165:6599-6605.
38. Nabe T., Hosokawa F., Matsuya K., Morishita T., Ikedo A., Fujii M., et al. Important role of neutrophils in the late asthmatic response in mice. Life Sci 2011, 88:1127-1135.
39. Bousquet J., Jeffery P.K., Busse W.W., Johnson M., Vignola A.M. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000, 161:1720-1745.
40. Little S.A., MacLeod K.J., Chalmers G.W., Love J.G., McSharry C., Thomson N.C. Association of forced expiratory volume with disease duration and sputum neutrophils in chronic asthma. Am J Med 2002, 15:446-452.
41. Leckie M.J., ten Brinke A., Khan J., Diamant Z., O'Connor B.J., Walls C.M., et al. Effects of interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet 2000, 356:2144-2148.
42. Kips J.C., O'Connor B.J., Langley S.J., Woodcock A., Kerstjens H.A., Postma D.S., et al. Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. Am J Respir Crit Care Med 2003, 167:1655-1659.
43. Louis R., Djukanovic R. Is the neutrophil a worthy target in sever asthma and chronic obstructive pulmonary disease?. Clin Exp Allergy 2006, 36:563-567.
44. Wenzel S.E., Szefler S.J., Leung D.Y., Sloan S.I., Rex M.D., Martin R.J. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997, 156:737-743.
45. Jatakanon A., Uasuf C., Maziak W., Lim S., Chung K.F., Barnes P.J. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999, 160:1532-1539.
46. Green R.H., Brightling C.E., Woltmann G., Parker D., Wardlaw A.J., Pavord I.D. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002, 57:875-879.
47. Hamelmann E., Oshiba A., Schwarze J., Bradley K., Loader J., Larsen G.L., et al. Allergen-specific IgE and IL-5 are essential for the development of airway hyperresponsiveness. Am J Respir Cell Mol Biol 1997, 16:674-682.
48. Kumar R.K., Forster P.S. Modeling allergic asthma in mice: pitfalls and opportunities. Am J Respir Cell Mol Biol 2002, 27:267-272.
49. Rankin J.A., Picarella D.E., Gebe G.P., Temann U.A., Prasad B., Dicosmo B., et al. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocyte and eosinophilic inflammation without airway hyperreactivity. Proc Natl Acad Sci USA 1996, 93:7821-7825.
50. Zhu Z., Homer R.J., Wang Z., Chen Q., Geba G.P., Wang J., et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiological abnormalities, and eotaxin production. J Clin Invest 1999, 103:779-788.
51. Tanaka H., Komai M., Nagao K., Ishizaki M., Kajiwara D., Takatsu K., et al. Role of interleukin-5 and eosinophils in allergen-induced airway remodeling in mice. Am J Respir Cell Mol Biol 2004, 31:62-68.